Results from a number of highly anticipated phase 3 clinical trials across the range of gynaecological...

Interim results from the phase 2 ENZA-p study (NCT04419402) show that adding 177Lu-PSMA-617 to enzalutamide...

Positive results from the TROPION-Breast01 phase 3 trial showed that a specifically engineered TROP2...

Shared decision-making is more than being attentive to patients’ needs or concerns – it also represents...

A multidisciplinary surgical approach implemented at the Mater Hospital, Dublin, has improved outcomes...

This year’s Gathering Around Cancer will be one of the highlights of the cancer conference calendar...

Welcome to the latest edition of Update Oncology and Haematology. Despite the ongoing pressure on healthcare...

Cervical cancer is predominantly a disease of younger women, with over 58 per cent of patients...

Co-chairs of the Irish Melanoma Forum Prof Shirley Potter and Prof Des Tobin discuss this year’s...

Targeted therapies in metastatic prostate cancer and the implications of the Triton3 trial. Prostate...

Colorectal cancer (CRC) is the third most common cancer globally.4,5 It accounts for approximately 10 per...

The annual ISMO meeting heard presentations on a wide range of high-quality cancer research taking ...